My guess is it's a "Sell on the News" action. This isn't the first time CRSP has shown high amplitude price change as this histogram shows:
https://schrts.co/NSfSbXYF
I think it will be important to watch the transition of this company from basically a 'research' business to one of product development and distribution. Somewhere along the way they'll have to show a profit to reward those who've invested in them. I'm fond of watching the Accumulation/Distribution activity to see what is happening with strong and weak hands holding the stock. In the mean time I plan on trimming and backfilling my position as the price moves around. I last added 12% to my position at $47.56 in August and had the opportunity to part with 10% of the holding at $69.57 a few weeks ago. The core position remains.
With each cycle of the price the portfolio builds out a bit.
Hope this helps,
OAG
Buy from the Scared; Sell to the Greedy.....
Recent CRSP News
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 12/10/2024 06:34:45 PM
- CRISPR Therapeutics Presents Data at the 2024 American Society of Hematology (ASH) Annual Meeting • GlobeNewswire Inc. • 12/09/2024 05:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/04/2024 10:35:03 PM
- CRISPR Therapeutics to Present at the Jefferies London Healthcare Conference • GlobeNewswire Inc. • 11/14/2024 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/13/2024 10:35:03 PM
- CRISPR Therapeutics to Present at the Guggenheim Inaugural Healthcare Innovation Conference • GlobeNewswire Inc. • 11/07/2024 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/05/2024 02:10:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/05/2024 02:05:08 PM
- CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results • GlobeNewswire Inc. • 11/05/2024 02:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/18/2024 09:35:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/18/2024 09:35:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/18/2024 09:35:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/18/2024 09:35:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/18/2024 09:35:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/15/2024 10:00:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/15/2024 10:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/12/2024 10:45:42 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 08/05/2024 09:22:43 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/05/2024 08:54:10 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/05/2024 08:10:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/05/2024 08:05:11 PM
- CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/05/2024 08:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 12:06:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/31/2024 08:15:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/31/2024 08:15:03 PM
VAYK Renewed JV to Renovate Historic Landmark into "Most Sought-after Airbnb Place" in Downtown Atlanta • VAYK • Dec 12, 2024 9:36 AM
Silexion Is Addressing the MOST COMMON Human Cancer Gene Mutation With RNAi; Recent M&As in the Field Were for Tens of Billions - $SLXN • SLXN • Dec 11, 2024 9:22 AM
Actelis Networks Bags Significant Orders for Seattle and Washington D.C. New Report Shows Their Potential as Smart City Market.. • ASNS • Dec 11, 2024 8:30 AM
Consumer Automotive Finance, Inc. Cancels an Additional 50 Million Common Shares with Shareholder Commitment to Retire 250 Million More Common Shares • CAFI • Dec 10, 2024 1:30 PM
Strategic Investments Spark Renewed Interest in Multi-Club Ownership Models • MSGS • Dec 10, 2024 1:11 PM
Consumer Automotive Finance, Inc. (OTC: CAFI) Files Form 15c2-11 to Enhance Transparency and Compliance • CAFI • Dec 9, 2024 9:30 AM